Entocort EC Articles

Serevent Is Cleared For COPD

12 February 1998

N American Sales Growth Drives Astra

11 February 1998

High Hopes For New Products At Rhone-Poulenc

5 February 1998

Highlights Of Astra's Pipeline Presentation

30 January 1998

Parallel Import Challenge For Astra

28 January 1998

Astra R&D Update Seeks To Allay Market Fears

23 January 1998

Losec Boosts Sales At Astra For 1st Nine Months

4 November 1997

Medic-Aid's HaloLite to Be Launched Next Year

15 October 1997

Slow Growth Again For Astra In 2nd Qtr

12 August 1997

First Approval Of Astra's Colazide

24 July 1997

India's Kopran Plans Product Launches

17 July 1997

Swedish Drug Market In 1996, And Early '97

8 July 1997

Stock Commentary Europe

26 June 1997

Astra's Pulmicort Turbuhaler Cleared In USA

26 June 1997

Strength In Astra's R&D To Cushion Losec's Demise?

9 June 1997

Forest Labs At Risk In Fight To Return To Profits?

9 June 1997

Investors Impressed With Glaxo Wellcome Pipeline

12 May 1997

Shock Growth Slowdown At Sweden's Astra

23 April 1997

Short-Term Outlook Good For Astra

21 April 1997

Astra's Entocort: Update

17 March 1997

Currency Exchange Affects 1996 Sales At Astra

24 February 1997

Glaxo Wellcome Breaches IFPMA Marketing Code

3 February 1997

Astra May See Delay In Appoval Of Pulmicort In USA

20 January 1997

Continued Approval Of Blockbuster Products In '97?

23 December 1996

Six Major Launches Planned For 1997 As Part Of Astra's Growth Strategy

23 December 1996

Dutch Government Reimbursement Blacklist Rises To 35

9 December 1996

TACTIC Study Supports MDI Switching In Asthma

11 November 1996

APS' Ethical Drug Delivery Business Nears Fruition

11 November 1996

Astra Remains Strong In First Nine Months Of 96

11 November 1996

1st Approval For Oxis Turbuhaler; Astra's Future 3rd Biggest Drug?

21 October 1996

7% Pretax Profits Growth For Astra

19 August 1996

Astra Gets US "Approvable" Letter For Pulmicort Turbo

1 July 1996

Astra As Expected In First Quarter

20 May 1996

Astra Cuts Price Of Losec In Sweden

15 April 1996

Astra Launches Entocort CR In UK

25 March 1996

Astra Launches Entocort CR In UK

25 March 1996

Sweden's Pharma Market Expanded 12.7% In 1995

4 March 1996

Losec "Will Be The World's Top-Selling Drug In 2000"

26 February 1996

Astra Strengthens R&D With Increased Spending

4 December 1995

Fast growth In World asthma Market

27 November 1995

33% Sales Growth For Astra

13 November 1995

Swedish Pharma Market Jan-Sept 1995

6 November 1995

Astra Posts Strong Growth Slightly Ahead Of Forecasts

4 September 1995

UK's MCA announce OTC plans

7 August 1995

Outstanding 1st Qtr Performance For Astra

22 May 1995

Astra Data Submission

20 March 1995

Astra Files For Entocort Capsules In UK

13 March 1995

Astra Pretax Profit Rockets 23%, Fuelled By Losec

27 February 1995

European Stock Comment

19 December 1994

EUROPE STOCK COMMENT

12 December 1994

Losec For GERD Maintenance In USA

12 December 1994

Astra Updates On Its R&D Pipeline

5 December 1994

Strong Sales And Profits Growth At Astra

21 November 1994

Astra Merck: New Stand-Alone Company

7 November 1994

Budesonide Effective In Crohn's Disease

3 October 1994

Budesonide Advantages

8 August 1994

STRONG FIRST QTR FOR ASTRA

23 May 1994

D&TB: NEGATIVE REVIEW OF FLIXOTIDE

9 May 1994

ASTRA'S SHARE PRICE TAKES TEMPORARY DIP

4 April 1994

NEBULIZED BECOTIDE WITHDRAWN IN UK

21 March 1994

STRONG 1993 RESULTS POSTED BY ASTRA

7 March 1994

EUROPEAN STOCK COMMENT

28 February 1994

SWEDISH PHARMA MARKET GROWTH SLOWDOWN

28 February 1994

ASTRA'S RHINOCORT APPROVED IN USA

21 February 1994

EXPANDING PHARMA MARKET IN TURKEY

10 January 1994

PULMICORT APPROVED IN GERMANY

6 December 1993

GLAXO REAFFIRMS COMMITMENT TO R&D

6 December 1993

ASTRA BROADENS RESEARCH BASE

29 November 1993

EUROPEAN STOCK COMMENT

22 November 1993

POWERFUL GAINS AS ASTRA STRENGTHENS

22 November 1993

ASTRA'S ROXIAM HITS TOXICITY TROUBLE

8 November 1993

ASTRA STRONG IN 1st HALF 1993

6 September 1993

PULMICORT TILADE TRIAL

26 July 1993

PRETAX PROFITS SOAR AT ASTRA

24 May 1993

ABPI SEES 14 BREACHES OF PRACTICE CODE

12 April 1993

SWEDEN'S PHARMA MARKET IN 1992

5 April 1993

FIRST ASTHMA LAUNCH FOR FLIXOTIDE

15 March 1993

SWEDISH STUDY SAYS FLIXONASE IS COSTLY

8 March 1993

PRETAX AND EPS SOAR AT ASTRA IN 1992

1 March 1993

LOSEC SALES TO TOP $1 BILLION IN 1992

21 December 1992

ASTRA IS CHEM INSIGHT'S STAR PERFORMER

14 December 1992

33% INTERIM PROFIT RISE AT ASTRA

7 September 1992

Astra 1991 results see losec boost

6 July 1992

LOSEC SALES ROCKET FOR ASTRA

25 May 1992

UK LAUNCH FOR LOW-DOSE PULMICORT

3 February 1992

FISONS UPDATES ON LEAD R&D PRODUCTS

27 January 1992

Jan Lundberg tells the Marketletter how AstraZeneca is turning around its pipeline